Compounds > beta-aminoethyl isothiourea
Page last updated: 2024-10-22

beta-aminoethyl isothiourea and Sarcoma 180

beta-aminoethyl isothiourea has been researched along with Sarcoma 180 in 2 studies

beta-Aminoethyl Isothiourea: A radiation-protective agent that can inhibit DNA damage by binding to the DNA. It also increases the susceptibility of blood cells to complement-mediated lysis.

Sarcoma 180: An experimental sarcoma of mice.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
TOLKACHEVA, EN1
SHAPIRO, NI1
Calcutt, G1
Ting, SM1
Preece, AV1

Other Studies

2 other studies available for beta-aminoethyl isothiourea and Sarcoma 180

ArticleYear
THE USE OF PROTECTIVE SUBSTANCES FOR DIFFERENTIAL CHANGES OF RADIOSENSITIVITY IN NORMAL AND TUMOR TISSUES.
    Acta - Unio Internationalis Contra Cancrum, 1964, Volume: 20

    Topics: Animals; beta-Aminoethyl Isothiourea; Carcinoma; Carcinoma, Ehrlich Tumor; Cystamine; Diethylstilbes

1964
Tissue NAD levels and the response to irradiation of cytotoxic drugs.
    British journal of cancer, 1970, Volume: 24, Issue:2

    Topics: Animals; beta-Aminoethyl Isothiourea; Cysteamine; Female; Lymphoma; Male; Mechlorethamine; Mice; NAD

1970